共 50 条
- [21] Enzalutamide monotherapy: Phase II study results in patients with hormone-naive prostate cancerJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)Tombal, BertrandBorre, MichaelRathenborg, PerWerbrouck, PatrickHeidenreich, AxelIversen, PeterBaskin-Bey, Edwina S.Perabo, FrankPhung, DeSmith, Matthew Raymond
- [22] Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell CarcinomaCLINICAL CANCER RESEARCH, 2021, 27 (17) : 4717 - 4725Kilgour, James M.Shah, AatmanUrman, Nicole M.Eichstadt, ShaundraDo, Hanh N.Bailey, IreneMirza, AmarLi, ShufengOro, Anthony E.Aasi, Sumaira Z.Sarin, Kavita Y.
- [23] Antitumor activity of MDV3100 in a phase I/II study of castration-resistant prostate cancer (CRPC)JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)Scher, H. I.Beer, T. M.Higano, C. S.Taplin, M.Efstathiou, E.Anand, A.Hung, D.Hirmand, M.Fleisher, M.
- [24] An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapyANNALS OF ONCOLOGY, 2008, 19 (01) : 92 - 98Van Cutsem, E.Siena, S.Humblet, Y.Canon, J. -L.Maurel, J.Bajetta, E.Neyns, B.Kotasek, D.Santoro, A.Scheithauer, W.Spadafora, S.Amado, R. G.Hogan, N.Peeters, M.
- [25] The efficacy and safety of toripalimab combined with sorafenib for unresectable hepatocellular carcinoma: An open-label, prospective, single-arm phase II study.JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Yang, Xin-RongCheng, Jian-WenWu, SuiyiHu, BoQiu, Shuang-JianSun, Hui-ChuanFan, JiaZhou, Jian
- [26] A Multicenter, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Saroglitazar in Patients With Primary Biliary CholangitisCLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (04) : E00327Vuppalanchi, RajGonzalez-Huezo, Ma SaraiPayan-Olivas, RamonMunoz-Espinosa, Linda E.Shaikh, FarheenCruz-Lopez, Jose L. PioParmar, Deven
- [27] Phase I/II study of the androgen receptor antagonist MDV3100 in castration-resistant prostate cancerCANCER RESEARCH, 2008, 68 (09)Scher, Howard I.Beer, ThomaszHigano, Celestia S.Danila, Daniel C.Shelkey, JuliaHirmand, MohammedHung, DavidMorris, Michael J.Larson, Steve M.Sawyers, Charles L.
- [28] Anlotinib plus hormone therapy in patients with platinum-resistant recurrent ovarian cancer: A prospective, single-arm, open-label, phase II studyJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Wang, XipengLi, JiaruiZhang, PingWang, YizhiLu, XinXu, Hong
- [29] Phase I-II study of MDV3100 in castration resistant prostate cancer. The Prostate Cancer Clinical Trials consortiumEJC SUPPLEMENTS, 2008, 6 (12): : 51 - 52Scher, H.Beer, T.Higano, C.Logothetis, C.Shelkey, J.Hung, D.Hirmand, M.Larson, S.Fleisher, M.Sawyers, C.
- [30] Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid CancerJOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (21) : 2359 - +Wirth, Lori J.Brose, Marcia S.Sherman, Eric J.Licitra, LisaSchlumberger, MartinSherman, Steven, IBible, Keith C.Robinson, BruceRodien, PatriceGodbert, YannDe La Fouchardiere, ChristelleNewbold, KateNutting, ChristopherMisir, SoamnauthXie, RanAlmonte, AnaYe, WeifeiCabanillas, Maria E.